![Marnix Bosch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 29 319 $ al 31/05/2026
Marnix L.
Bosch currently works at Northwest Biotherapeutics, Inc., as Chief Technical Officer from 2000 and the University of Washington, as Affiliate Associate Professor.
Dr. Bosch also formerly worked at Rijksinstituut Voor Volksgezondheid En Milieu, as Head-Molecular Biology Department.
Dr. Bosch received his Masters Business Admin degree in 2003 from the University of Washington and doctorate degree in 1987 from the University of Leiden.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 14/11/2025 | 129.157 ( 0,01 % ) | 29 319 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| NORTHWEST BIOTHERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/01/2000 |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| Empresas | Cargo | Fin |
|---|---|---|
Rijksinstituut Voor Volksgezondheid En Milieu | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Northwest Biotherapeutics, Inc.
 Northwest Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes immunotherapy products | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Leiden
 University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rijksinstituut Voor Volksgezondheid En Milieu |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
